33 results on '"Jupudi, Srikanth"'
Search Results
2. Targeting Lipoxygenase Enzyme by Flavonoids from Tadehagi triquetrum: a Combined In Silico and In Vitro Approach
3. Revamped role for approved drug: integrative computational and biophysical analysis of saquinavir's peptidyl arginine deiminase 4 inhibition for rheumatoid arthritis.
4. Phytoconstituents of Citrus limon (Lemon) as Potential Inhibitors Against Multi Targets of SARS‐CoV‐2 by Use of Molecular Modelling and In Vitro Determination Approaches.
5. Identifying Potent Breast Cancer Inhibitors Against ERα Target Using Pharmacophore Model, 3D‐QSAR and MD Studies.
6. Potential Inhibitors from Natural Compounds against SARS‐CoV‐2 Main Protease: A Systematic Molecular Modelling Approach
7. Dipeptidyl peptidase-IV inhibitory action of Calebin A: An in silico and in vitro analysis
8. Virtual high throughput screening of natural peptides against ErbB1 and ErbB2 to identify potential inhibitors for cancer chemotherapy.
9. DFT calculation, molecular docking, and molecular dynamics simulation study on substituted phenylacetamide and benzohydrazide derivatives
10. Molecular insights in repurposing selective COX-2 inhibitor celecoxib against matrix metalloproteinases in potentiating delayed wound healing: a molecular docking and MMPB/SA based analysis of molecular dynamic simulations
11. Molecular insights in repurposing selective COX-2 inhibitor celecoxib against matrix metalloproteinases in potentiating delayed wound healing: a molecular docking and MMPB/SA based analysis of molecular dynamic simulations.
12. A Critical Review on the Potency of Phytoconstituents in the Management of COVID-19
13. A Review on Neuroinflammatory Pathway Mediating Through Ang-II/AT1 Receptors and a Novel Approach for the Treatment of Cerebral Ischemia in Combination with ARB’s and Ceftriaxone
14. Revisiting the South Indian Traditional Plants against Several Targets of SARS-CoV-2 - An in silico Approach
15. A Review on Neuroinflammatory Pathway Mediating Through Ang-II/AT1 Receptors and a Novel Approach for the Treatment of Cerebral Ischemia in Combination with ARB's and Ceftriaxone.
16. In-silico docking and molecular dynamic introspective study of multiple targets of AChE with Rivastigmine and NMDA receptors with Riluzole for Alzheimer's disease.
17. Drug target of natural products and COVID-19: how far has science progressed?
18. MurD inhibitors as antibacterial agents: a review
19. In-silicodocking and molecular dynamic introspective study of multiple targets of AChE with Rivastigmine and NMDA receptors with Riluzole for Alzheimer’s disease
20. Molecular Docking, MM-GBSA, and Molecular Dynamics Approach: 5-MeO-DMT Analogues as Potential Antidepressants.
21. Ceftriaxone induces glial EAAT‐2 promotor region via NF‐kB conformational changes: An interaction analysis using HADDOCK
22. INVESTIGATION OF ANTI-SARS COV-2 ACTIVITY OF SOME TETRAHYDRO CURCUMIN DERIVATIVES: AN IN SILICO STUDY
23. Identification of Papain-Like Protease inhibitors of SARS CoV-2 through HTVS, Molecular docking, MMGBSA and Molecular dynamics approach
24. Neuroprotective Effect of Scutellaria baicalensis in Parkinson’s disease and Multi-Target Mechanisms Based on Network Pharmacology
25. Virtual high throughput screening of natural peptides against ErbB1 and ErbB2 to identify potential inhibitors for cancer chemotherapy
26. Identification of Antimycobacterial Agent Using In Silico Virtual Screening, ADME Prediction, Docking, and Molecular Dynamics Simulations Approach
27. In Silico Studies of Isoflavones as Estrogen Receptor α (ERα) Activators Targeting Cardiovascular Diseases.
28. Multiwalled Carbon Nanotubes as Nanomaterial Tool in the Management of Prostate Cancer: A Possible Nanoformulation Approach.
29. Targeting Lipoxygenase Enzyme by Flavonoids from Tadehagi triquetrum: a Combined In Silicoand In VitroApproach
30. Dipeptidyl peptidase-IV inhibitory action of Calebin A: An in silicoand in vitroanalysis
31. Unveiling molecular insights: in silico exploration of TLR4 antagonist for management of dry eye syndrome.
32. The identification of c-Abl inhibitors as potential agents for Parkinson's disease: a preliminary in silico approach.
33. Rational design of thiazolidine-4-one-gallic acid hybrid derivatives as selective partial PPARγ modulators: an in-silico approach for type 2 diabetes treatment.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.